Biogen
BIIB
$127.04
Share price
0.40%
Change (1 day)
-43.68%
Change (1 year)
Categories
Biogen is an American biotech company based in Cambridge, Massachusetts. The company uses recombinant DNA technology, also known as biotechnology. This makes it possible to produce human proteins and therefore medicinal products with the help of microorganisms. The company continues to develop new substances and works on improving already approved molecules.
Earnings for Biogen (BIIB)
Earnings in 2025 (TTM): $1.75 Billion USD
According to Biogen's latest financial reports the company's current earnings are $9.81 Billion USD. In 2024 the company made an earning of $1.90 Billion USD, an increase over its 2023 earnings that were of $1.29 Billion USD. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for Biogen from 1996 to 2025
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2025 (TTM)  | $1.75 B | -8.06% |
| 2024 | $1.90 B | 46.98% |
| 2023 | $1.29 B | -63.9% |
| 2022 | $3.59 B | 105.81% |
| 2021 | $1.74 B | -65.43% |
| 2020 | $5.04 B | -29.17% |
| 2019 | $7.12 B | 20.79% |
| 2018 | $5.89 B | 15.03% |
| 2017 | $5.12 B | 3.97% |
| 2016 | $4.93 B | 3.48% |
| 2015 | $4.76 B | 20.79% |
| 2014 | $3.94 B | 59.1% |
| 2013 | $2.48 B | 33.72% |
| 2012 | $1.85 B | 8.41% |
| 2011 | $1.71 B | 39.13% |
| 2010 | $1.22 B | -7.71% |
| 2009 | $1.33 B | 15.47% |
| 2008 | $1.15 B | 26.74% |
| 2007 | $0.91 B | 85.02% |
| 2006 | $0.49 B | 92.11% |
| 2005 | $0.25 B | 299.73% |
| 2004 | $64.09 M | -106.82% |
| 2003 | -$0.94 Billion | -439.73% |
| 2002 | $0.27 B | -28.99% |
| 2001 | $0.38 B | -20.04% |
| 2000 | $0.48 B | 48% |
| 1999 | $0.32 B | 56.65% |
| 1998 | $0.21 B | 41.03% |
| 1997 | $0.14 B | 264.86% |
| 1996 | $40.82 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $6.65 B | 279.48% | 🇺🇸 USA |
 Gilead Sciences GILD | $6.82 B | 289.47% | 🇺🇸 USA |
 AbbVie ABBV | $3.62 B | 106.69% | 🇺🇸 USA |
 Pfizer PFE | $10.34 B | 490.10% | 🇺🇸 USA |
 Johnson & Johnson JNJ | $27.40 B | 1,464.03% | 🇺🇸 USA |
 Acorda Therapeutics
ACOR | -$0.28 Billion | -115.51% | 🇺🇸 USA |
 Sanofi SNY | $8.78 B | 401.05% | 🇫🇷 France |
 Bio-Rad Laboratories BIO | -$2.76 Billion | -256.94% | 🇺🇸 USA |
 Illumina ILMN | -$0.79 Billion | -144.57% | 🇺🇸 USA |
 Qiagen QGEN | $0.17 B | -89.77% | 🇳🇱 Netherlands |